The prevalence of vaginal infection is increasing among women, especially at reproductive age. For proper eradication of infection, the effective concentration of a drug is required at the infection site. Therefore, local delivery is recommended to exert a direct therapeutic effect at the site action that causes a reduction in dose and side effects. The main focus of vaginal drug delivery is to enhance retention time and patient compliance. The high recurrence rate of vaginal infection due to the lack of effective treatment strategies opens the door for new therapeutic approaches. To combat these setbacks, intravaginal gene therapies have been investigated. High attention has been gained by vaginal gene therapy, especially for sexually transmitted infection treatment. Despite much research, no product is available in the market, although in vitro and preclinical data support the vaginal route as an effective route for gene administration. The main focus of this review is to discuss the recent advancement in miniaturized polymeric systems for intravaginal gene therapies to treat local infections. An overview of different barriers to vaginal delivery and challenges of vaginal infection treatment are also summarised.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1381612829666230712162540 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intranasal immunization with CPAF combined with ADU-S100 induces an effector CD4 T cell response and reduces bacterial burden following intravaginal infection with Chlamydia muridarum.
Vaccine
January 2025
Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Chlamydia trachomatis (Ct) is the most common bacterial sexually transmitted infection globally, and a vaccine is urgently needed to stop transmission and disease. Chlamydial Protease Activity Factor (CPAF) is an immunoprevalent and immunodominant antigen for CD4 T cells and B cells, which makes it a strong vaccine candidate. Due to the tolerogenic nature of the female genital tract (FGT) and its lack of secondary lymphoid tissue, effective induction of protective cell-mediated immunity will likely require potent and safe mucosal adjuvants.
View Article and Find Full Text PDFArticle Synopsis
- Chlamydia trachomatis (Ct) is the most prevalent bacterial STI worldwide, highlighting the urgent need for an effective vaccine.
- The study focuses on Chlamydial Protease Activity Factor (CPAF), identified as a promising antigen for vaccine development due to its strong immune response in T and B cells.
- Researchers tested different mucosal adjuvants, finding that intranasal vaccination with CPAF and a specific adjuvant (CDA) was safe and effective in reducing infection in mice, indicating potential for a new Chlamydia vaccine.
Research Note: Evaluating the vertical transmission potential of Salmonella Reading in broiler breeders.
Poult Sci
December 2024
Department of Poultry Science, Mississippi State University, MS, 39762. Electronic address:
Article Synopsis
- Salmonella Reading (S. Reading) has emerged as a significant foodborne pathogen causing outbreaks linked to contaminated turkey products in North America, making understanding its transmission critical for prevention.
- This study involved infecting 32 broiler breeder hens with two different bioluminescent strains of S. Reading to investigate their ability to colonize the hens' reproductive tissues and contaminate eggs.
- Results indicated that the outbreak strain contaminated a higher percentage of eggshells compared to the nonoutbreak strain, suggesting S. Reading can effectively colonize and pose risks for egg contamination, with further research needed on its viability during incubation.
Sulfated glycosaminoglycans are host epithelial cell targets of the Candida albicans toxin candidalysin.
Nat Microbiol
October 2024
Institute for Infection and Immunity, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
Article Synopsis
- Candidalysin, produced by Candida albicans, is a virulence factor that damages host cells, and this study identified specific genes related to glycosaminoglycan (GAG) biosynthesis that, when disrupted, confer resistance to this damage.
- Researchers found that candidalysin binds to sulfated GAGs on the host cell surface, which helps it to cause damage, but adding exogenous sulfated GAGs like dextran sulfate can protect cells and inhibit candidalysin's effects.
- In a mouse model of vulvovaginal candidiasis, applying dextran sulfate reduced tissue damage and inflammation, suggesting sulfated GAGs are potential therapeutic targets to counteract candidalysin-related damage.
A Simple and Versatile Method for Ex Vivo Monitoring of Goat Vaginal Mucosa Transduction by Viral Vector Vaccines.
Vaccines (Basel)
July 2024
Department of Veterinary Science, University of Parma, 43126 Parma, Italy.
Goat may represent a valid large animal model for human pathogens and new vaccines testing. Appropriate vaccine administration is a critical component of a successful immunization program. The wrong route of administration may reduce the efficacy of the vaccine, whereas the proper administration strategy can enhance it.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!